Massivemarkets

SEC Form 4

Medpace Holdings, Inc. (MEDP) insider trading

In the 12 months to Oct 24, 2026, 9 MEDP insiders reported open-market sales of $467.0M across 39 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$467.0M
39 filings · 9 insiders
Open-market purchases
$0
0 filings
Pre-arranged sales (10b5-1)
1 of 39
$12.8M of $467.0M sold (3%)

Who traded MEDP, and when

  • Sale
  • Sale, pre-arranged (10b5-1)

MEDP daily close from Oct 24, 2025 to Oct 23, 2026, between $393.42 and $669.20, last $669.20. 39 sale and 0 purchase filings by 9 insiders, marked at their filing dates. August J. Troendle, CEO → President & CEO: sold $358.5M across 21 filings, first filed Nov 14, 2025, last Oct 1, 2026. Jesse J. Geiger, President: sold $41.1M across 3 filings, first filed Oct 29, 2025, last Mar 19, 2026. Susan E. Burwig, Exec. VP, Operations: sold $28.8M across 4 filings, first filed Oct 29, 2025, last Jul 29, 2026. Stephen P. Ewald, General Counsel & Corp. Secy.: sold $16.5M across 2 filings, first filed Oct 29, 2025, last Jun 1, 2026. Fred B. Davenport Jr., Director: sold $7.9M across 2 filings, first filed Nov 3, 2025, last Aug 21, 2026. Robert O. Kraft, Director: sold $6.2M across 2 filings, first filed Nov 18, 2025, last Aug 28, 2026. 3 others: sold $8.1M across 5 filings, first filed Nov 25, 2025, last Aug 24, 2026.

Largest mark · tap a row for others

August J. Troendle · CEO

Filing 1 of 2 within a week · $78,998,895 total

Sale $17,031,557

28,688 shares at $593.68 avg

Filed Nov 24, 2025 · traded Nov 20

Close on filing date $618.49

MEDP daily closelast $669.20

August J. Troendle · CEO → President & CEO

$358.5M sold

Jesse J. Geiger · President

$41.1M sold

Susan E. Burwig · Exec. VP, Operations

$28.8M sold

Stephen P. Ewald · General Counsel & Corp. Secy.

$16.5M sold

Fred B. Davenport Jr. · Director

$7.9M sold

Robert O. Kraft · Director

$6.2M sold

3 others

$8.1M sold
One row per insider, smaller filers combined; marks sit at the SEC filing date, sized by dollar value.

Has Medpace Holdings, Inc.'s CEO sold stock?

Yes. August J. Troendle (CEO) sold 586,377 shares ($358.5M) between Nov 2025 and Oct 2026.

Open-market trades

39 filings in the last 12 months
InsiderRoleSoldBoughtFilingsPre-arranged (10b5-1)Last filed
August J. TroendleCEO → President & CEO$358.5M—21—
Jesse J. GeigerPresident$41.1M—331% of sales
Susan E. BurwigExec. VP, Operations$28.8M—4—
Stephen P. EwaldGeneral Counsel & Corp. Secy.$16.5M—2—
Fred B. Davenport Jr.Director$7.9M—2—
Robert O. KraftDirector$6.2M—2—
Kevin M. BradyCFO & Treasurer$3.9M—2—
Brian T. CarleyDirector$3.0M—1—
Cornelius P. McCarthy IIIDirector$1.2M—2—
Other insider activity (not market trades) · 38 records
  • Option exercises37 records
  • Gifts1 record

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

Build this yourself

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Agent prompt

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MEDP every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Role
The title on each filing. Someone whose title changed shows more than one.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.